Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
New Biotechnology|May 30, 2017
Guiding recombinant antivenom development by omics technologiesAndreas H LaustsenTrends in Immunology|March 27, 2024
Recombinant snake antivenoms get closer to the clinicAndreas H LaustsenExpert Opinion on Drug Discovery|August 1, 2019
How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?Andreas H LaustsenTropical Medicine and Infectious Disease|October 3, 2018
Recent Advances in Next Generation Snakebite AntivenomsCecilie Knudsen, Andreas H LaustsenDrug Discovery Today|October 23, 2025
Advances in antibody-based strategies for targeting cancer-associated glycopeptide antigensEdward P W Meier, Andreas H LaustsenAnnual Review of Pharmacology and Toxicology|August 1, 2024
Progress and Challenges in the Field of Snakebite Envenoming TherapeuticsJosé María Gutiérrez, Nicholas R Casewell, Andreas H LaustsenThe Journal of Venomous Animals and Toxins Including Tropical Diseases|December 20, 2023
Towards better antivenoms: navigating the road to new types of snakebite envenoming therapiesSuthimon Thumtecho, Nick J Burlet, Anne Ljungars, et al.Journal of Proteomics|September 6, 2016
Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleucaLine P Lauridsen, Andreas H Laustsen, Bruno Lomonte, et al.Plos Neglected Tropical Diseases|February 4, 2017
Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?Andreas H Laustsen, Kristoffer H Johansen, Mikael Engmark, et al.Journal of Proteomics|February 16, 2016
Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps)Line P Lauridsen, Andreas H Laustsen, Bruno Lomonte, et al.Pageof 9